Compare EVMN & MRLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVMN | MRLN |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United States | United States |
| Employees | 48 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 825.5M | 915.1M |
| IPO Year | N/A | 2024 |
| Metric | EVMN | MRLN |
|---|---|---|
| Price | $22.86 | $7.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $43.88 | $25.00 |
| AVG Volume (30 Days) | 341.8K | ★ 1.3M |
| Earning Date | 06-11-2026 | 10-28-2021 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.89 | $5.78 |
| 52 Week High | $33.20 | $17.00 |
| Indicator | EVMN | MRLN |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 41.42 |
| Support Level | $21.39 | $6.22 |
| Resistance Level | $23.08 | $17.00 |
| Average True Range (ATR) | 1.43 | 0.86 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 45.87 | 30.43 |
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Merlin Inc is focused on developing autonomous flight software for legacy and next-generation airborne systems. Its aircraft-agnostic, AI-based software supports takeoff-to-landing autonomous operations for military and civil aviation programs. The company aims to build an AI-based operating software platform intended to support autonomous flight operations across a range of aircraft types.